News

U.S. Treasury Secretary Bessent: Hopes to pass the Clarity Act before Congress goes on vacation.

U.S. Treasury Secretary Bessant: (Talking about U.S. government funding) We don’t need another shutdown.

U.S. Treasury Secretary Bessent: The COVID-19 epidemic is a supply chain test in the conflict between major powers.

U.S. Treasury Secretary Bessent: Canada has seriously discriminatory policies regarding dairy products, alcohol and beverages.

U.S. Treasury Secretary Bessenter: (Regarding trade with Canada) This is just a reciprocal measure.

According to a Reuters survey: 78 out of 104 economists (78 out of 102 in last month's survey) expect the Federal Reserve to keep the federal funds rate unchanged at 3.50%-3.75% throughout 2026.

According to a Reuters survey: 104 economists all expect the Federal Reserve to keep the federal funds rate unchanged at 3.50%-3.75% on July 29.

US President Trump will deliver a speech at Lindsey Graham’s funeral on July 28, local time.

U.S. Treasury Secretary Bessent: Trying to create market signals through the government holding company shares.

ADP Weekly Employment Report: U.S. hiring slows for fourth straight week.

U.S. Treasury Secretary Bessent: (About the U.S. economy) 3% growth is not unreasonable.

The weekly change in U.S. ADP employment numbers for the week to July 4 will be released in ten minutes.

U.S. Treasury Secretary Bessent: He believes that US$350 million in expenditures can be saved this year through payment reform.

U.S. Treasury Secretary Bessent: $100 million saved by stopping payments to deceased people.

German Chancellor Mertz: Hopes to strengthen cooperation with Azerbaijan in the next few years, especially in the energy field.

BAE Systems, Boeing (BA.N) and Saab have signed an agreement to advance cooperation on training UK pilots based on the Boeing T-7 system.

Indian External Affairs Minister S. Jaishankar will visit Manila from July 22 to 23.

Eli Lilly (LLY.N) U.S. stocks fell slightly before the market opened, and are now down 0.58%.

Novo Nordisk (NVO.N): is suing Eli Lilly (LLY.N) in U.S. federal court, accusing it of making false claims in ads for obesity drugs.

Novo Nordisk (NVO.N) sued Eli Lilly (LLY.N) in U.S. federal court, accusing it of violating the Lanham Act, court records show.